Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database · 1 strong · 1 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	PEDMARK by Fennec Pharmaceuticals	Fennec Pharmaceuticals	Therapeutic	-	Small Molecule	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	98%	PediatricCisplatin Ototoxicity	Cisplatin-Induced Hearing LossHearing Loss

Fennec Pharmaceuticals · Small Molecule · Marketed

MarketedTherapeuticStronger sources

Evidence

regulatory

Confidence

98%

Indications

Cisplatin-Induced Hearing LossHearing Loss

Population

PediatricCisplatin Ototoxicity